AMERIPRISE FINANCIAL INC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$224,457
-12.3%
8,785
-1.5%
0.00%
Q2 2023$255,912
+21.2%
8,923
+1.3%
0.00%
Q1 2023$211,127
-19.7%
8,808
-43.3%
0.00%
Q4 2022$263,000
+26.4%
15,530
+10.8%
0.00%
Q3 2022$208,000
-25.4%
14,020
+140.5%
0.00%
Q3 2021$279,000
-32.8%
5,830
-39.0%
0.00%
Q4 2020$415,000
-82.8%
9,559
-83.0%
0.00%
-100.0%
Q3 2020$2,416,000
-26.5%
56,324
-19.9%
0.00%0.0%
Q2 2020$3,286,00070,3020.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders